TILDA® acts as a combined drug that provides muscle relaxation via chlorzoxazone, while paracetamol and diclofenac provide analgesic, antipyretic, and anti-inflammatory effects by inhibiting prostaglandin synthesis.

Yes, it is contraindicated in patients with active gastrointestinal ulcers or bleeding, severe hepatic or renal insufficiency, congestive heart failure, ischemic heart disease, or hypersensitivity to NSAIDs, including aspirin-induced asthma.

The recommended dose is 1 tablet 2-3 times a day after meals, with a maximum daily dose of 3 tablets. The duration of treatment should not exceed 5-7 days.

Yes, the film coating contains quinoline yellow dye (E 104), which may cause allergic reactions in sensitive individuals.